Nov 16, 2021 08:07 PM (GMT+8) · EqualOcean
Kailaiying announced that in the process of continuously providing contract customized R & D and production (cdmo) services for a small molecule chemical innovative drug of a large pharmaceutical company in the United States, the company's wholly-owned subsidiaries asymchem, Inc. and Jilin kailaiying Pharmaceutical Chemistry Co., Ltd. recently signed a new batch of supply contracts for related products with a large pharmaceutical company in the United States, As of the signing date of the contract, the cumulative contract amount of cdmo service of the product was US $480 million.